Recruiting Heart Attack Studies in Madrid
An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
The primary objective of this study is to evaluate the long-term safety of mRNA-3705 administered to participants with isolated methylmalonic acidemia (MMA) due to methylmalonyl-coenzyme A mutase (MUT...
Ribociclib (LEE011) Rollover Study for Continued Access
This study is to allow continued use of ribociclib (LEE011) as single agent or in combination with other investigational treatments in patients benefitting from treatment in an eligible Novartis-spons...
About Heart Attack Clinical Trials in Madrid
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Madrid, . These studies are seeking a combined 113 participants. Research is being sponsored by ModernaTX, Inc., Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Madrid — FAQ
Are there heart attack clinical trials in Madrid?
Yes, there are 2 heart attack clinical trials currently recruiting in Madrid, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Madrid?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Madrid research site will contact you about next steps.
Are clinical trials in Madrid free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Madrid studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Madrid are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov